vTv Therapeutics Inc. (NASDAQ: VTVT) Stock Information | RedChip

vTv Therapeutics Inc. (NASDAQ: VTVT)


$15.5700
+1.3900 ( +10.90% ) 5.9K

vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Itsproduct pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.

Market Data


Open


$15.5700

Previous close


$14.1800

Volume


5.9K

Market cap


$40.20M

Day range


$14.1800 - $15.5900

52 week range


$7.3800 - $30.9900

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Nov 19, 2024
8-k 8K-related 15 Nov 12, 2024
10-q Quarterly Reports 64 Nov 12, 2024
8-k 8K-related 13 Oct 25, 2024
10-q Quarterly Reports 64 Aug 08, 2024
8-k 8K-related 15 Aug 08, 2024
8-k 8K-related 14 Jul 26, 2024
8-k 8K-related 13 Jul 02, 2024
4 Insider transactions 1 Jun 27, 2024
4 Insider transactions 1 Jun 27, 2024

Latest News